New Drug Approvals Archive - September 2007
New Dosage Regimen: August 30, 2007
Date of Approval: September 6, 2007
Totect (dexrazoxane) is a topoisomerase inhibitor used as a detoxifying agent for the treatment of extravasation resulting from intravenous anthracycline chemotherapy.
Norditropin (somatropin [rDNA origin])
New Indication Approved: September 20, 2007
Azor (amlodipine and olmesartan) Tablets - formerly amlodipine and olmesartan
Date of Approval: September 26, 2007
Azor is a fixed-dose combination of two antihypertensives, the calcium channel blocker amlodipine besylate and the angiotensin receptor blocker olmesartan medoxomil. Azor is indicated for the treatment of hypertension.
Afluria (influenza virus vaccine)
Date of Approval: September 28, 2007
Afluria (influenza virus vaccine) is an inactivated influenza virus vaccine, indicated for active immunization of persons ages 18 years and older against influenza disease.
Azor (amlodipine and olmesartan)
New Indication Approved: May 11, 2009